Mayne Pharma | MYX - Cost Of Sales

Stock Price
2.20
Daily Change
0.07 3.29%
Monthly
-15.71%
Yearly
-69.57%
Q1 Forecast
2.33

Mayne Pharma reported AUD43.74M in Cost of Sales for its fiscal semester ending in June of 2024.





Cost Of Sales Change Date
Ansell USD 605.3M 351.2M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Healius AUD 218.7M 110.8M Jun/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Medical Developments International AUD 7.09M 4.91M Dec/2025
Nanosonics AUD 24.22M 1.11M Dec/2025
Polynovo AUD 9.02M 3.51M Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 536.28M 21.52M Dec/2025
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025